S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
OTCMKTS:CLABF

Core One Labs News Headlines

$1.44
+0.35 (+32.54%)
(As of 01/14/2022 03:55 PM ET)
Add
Compare
Today's Range
$1.14
$1.44
50-Day Range
$0.46
$1.73
52-Week Range
$0.36
$4.25
Volume
103,000 shs
Average Volume
80,510 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get Core One Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLABF and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Core One Labs Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLABF
News Sentiment

1.32

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLABF Articles
This Week

2

1

CLABF Articles
Average Week



Core One Labs (OTCMKTS:CLABF) News Headlines Today

SourceHeadline
finance.yahoo.com logoCore One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022
finance.yahoo.com - January 15 at 11:13 PM
finance.yahoo.com logoCore One Labs Now Also Working to Biosynthesize DMT and Receives License
finance.yahoo.com - January 8 at 11:22 PM
MarketBeat logoShort Interest in Core One Labs Inc. (OTCMKTS:CLABF) Expands By 19.8%
americanbankingnews.com - January 8 at 5:24 AM
benzinga.com logoCore One Labs Applauds Health Canada's Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments
benzinga.com - January 6 at 12:47 AM
finance.yahoo.com logoCore One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments
finance.yahoo.com - January 5 at 7:46 PM
msn.com logoPsychedelics Company Core One Labs Dives Into Functional Mushrooms With New $3M Acquisition
msn.com - December 27 at 3:24 PM
finance.yahoo.com logoCore One Labs Acquires New Path Laboratories
finance.yahoo.com - December 23 at 8:20 PM
benzinga.com logoCore One's Dr. Robert E.W. Hancock to Host Virtual Townhall Webcast and Present on Proprietary Biosynthesized Psilocybin Wednesday, August 4, 2021
benzinga.com - July 30 at 3:49 AM
finance.yahoo.com logoCore One Labs Announces Details of Consolidation to Meet Nasdaq Listing Requirements
finance.yahoo.com - July 16 at 6:53 AM
finance.yahoo.com logoREPEAT - New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
finance.yahoo.com - June 21 at 1:45 PM
finance.yahoo.com logoNew Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed
finance.yahoo.com - June 19 at 6:52 PM
benzinga.com logoCore One Labs Retains Canada's Highest-Ranked IP Law Firm to Assist With Patent Filings
benzinga.com - June 18 at 9:05 AM
finance.yahoo.com logoCore One Labs Retains Canada’s Highest-Ranked IP Law Firm to Assist With Patent Filings
finance.yahoo.com - June 18 at 4:04 AM
finance.yahoo.com logoCore One Labs Plans Share Consolidation in Preparation of Listing its Common Shares on Nasdaq
finance.yahoo.com - June 16 at 10:04 AM
finance.yahoo.com logoREPEAT - Core One Labs’ Biosynthesized Psilocybin Provisional Patent Imminent
finance.yahoo.com - June 14 at 9:36 AM
finance.yahoo.com logoCore One Labs Inc. (CLABF)
finance.yahoo.com - June 11 at 12:21 AM
finance.yahoo.com logoCore One Labs Provides Clarification on Trading Activity
finance.yahoo.com - May 21 at 9:40 AM
finance.yahoo.com logoREPEAT – Core One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
finance.yahoo.com - May 6 at 11:51 AM
finance.yahoo.com logoCore One Labs Commences Development on Patent Pending Psychedelic Drug Formulation for the Treatment of Alzheimer’s Disease
finance.yahoo.com - May 6 at 6:50 AM
finance.yahoo.com logoREPEAT - World Renowned Physician Joins Core One Labs as Chief Medical Officer
finance.yahoo.com - May 5 at 1:41 PM
finance.yahoo.com logoCore One Labs Unaware of Any Material Change that Would Account for Significant Share Price Depreciation
finance.yahoo.com - May 4 at 7:45 PM
finance.yahoo.com logoREPEAT - Core One Labs Completes Milestone Acquisition of Akome Biotech
finance.yahoo.com - May 4 at 9:44 AM
finance.yahoo.com logoCore One Labs Appoints Patent Expert, Dr. Dan Polonenko, To Advisory Board
finance.yahoo.com - April 30 at 1:50 AM
finance.yahoo.com logoREPEAT -- Core One Labs Reaches Definitive Agreement to Acquire Akome Biotech
finance.yahoo.com - April 29 at 10:08 AM
finance.yahoo.com logoREPEAT -- Core One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
finance.yahoo.com - April 28 at 1:17 PM
finance.yahoo.com logoCore One Labs to Explore Joint Venture with Lobe Sciences for the Clinical Development of Biosynthetic Psilocybin
finance.yahoo.com - April 28 at 8:17 AM
finance.yahoo.com logoEmerging Markets Report: The Rich Get Richer
finance.yahoo.com - April 26 at 12:28 PM
finance.yahoo.com logoRepeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
finance.yahoo.com - April 26 at 12:28 PM
finance.yahoo.com logoCore One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
finance.yahoo.com - April 24 at 6:18 PM
finance.yahoo.com logoCore One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
finance.yahoo.com - April 21 at 10:03 AM
finance.yahoo.com logoREPEAT: Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
finance.yahoo.com - April 21 at 10:03 AM
finance.yahoo.com logoCore One Labs Negotiates Milestone Acquisition With Akome Biotech Ltd.
finance.yahoo.com - April 17 at 8:09 PM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
finanznachrichten.de - April 14 at 11:36 PM
finance.yahoo.com logoCore One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
finance.yahoo.com - April 14 at 11:36 PM
finance.yahoo.com logoEmerging Markets Report: A Moment for the Mushroom
finance.yahoo.com - April 14 at 1:35 PM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs Vocan Expands Product Commercialization Team
finanznachrichten.de - April 6 at 7:37 AM
finance.yahoo.com logoCore One Labs Vocan Expands Product Commercialization Team
finance.yahoo.com - April 6 at 7:37 AM
finance.yahoo.com logoCore One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF
finance.yahoo.com - March 31 at 11:43 AM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs Appoints Dr. Stephen Peach as Head of Patient Research
finanznachrichten.de - March 28 at 5:14 PM
finance.yahoo.com logoCore One Labs Appoints Dr. Stephen Peach as Head of Patient Research
finance.yahoo.com - March 28 at 5:14 PM
finance.yahoo.com logoRepeat: Core One Labs Files Application to List its Common Shares on NASDAQ
finance.yahoo.com - March 22 at 1:00 PM
bloomberg.com logoCore One Labs Inc
bloomberg.com - March 21 at 2:30 PM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs to Commence Trading in the US on OTC Pink Market
finanznachrichten.de - March 15 at 12:22 AM
finance.yahoo.com logoCore One Labs to Commence Trading in the US on OTC Pink Market
finance.yahoo.com - March 15 at 12:22 AM
finanznachrichten.de logoCore One Labs Inc.: Psychedelic Expert Core One Labs Reports Milestone Acquisition
finanznachrichten.de - March 12 at 7:19 AM
finance.yahoo.com logoPsychedelic Expert Core One Labs Reports Milestone Acquisition
finance.yahoo.com - March 12 at 7:19 AM
finance.yahoo.com logoCore One Labs in Collaboration with KICT to Explore DMT Assisted Psychotherapy
finance.yahoo.com - March 9 at 8:47 AM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs' Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil
finanznachrichten.de - March 4 at 4:57 PM
finance.yahoo.com logoCore One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil
finance.yahoo.com - March 4 at 4:57 PM
finanznachrichten.de logoCore One Labs Inc.: Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
finanznachrichten.de - February 26 at 10:02 AM
Get Core One Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLABF and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.